| Announce Date | 12/04/2025 |
| EPS Normalized Actual | $0.516 (Miss by $-0.354) |
| EPS GAAP Actual | $0.516 (Miss by $-0.354) |
| Revenue Actual | $0.616217B |
| Revenue Surprise | Beat by $616.217M |
| Announce Date | 02/02/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.36 |
| EPS GAAP Estimate | $3.36 |
| Revenue Estimate | $0.742B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2028 | 2.6 | 11.16 | 2.57862 | 2.61663 | 1 |
| Feb 2028 | 3.59 | 8.08 | 3.56048 | 3.61297 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.52 | 0.52 | 0.616217B | 3.23% | 616.22M |
| FQ3 2025 (Aug 2025) | -1.79 | -1.79 | 0.545965B | 3.81% | 545.97M |
| FQ2 2025 (May 2025) | -2.02 | -2.02 | 0.473973B | 3.46% | 473.97M |
| FQ1 2025 (Feb 2025) | 2.99 | 2.99 | 0.745949B | 0.94% | 745.95M |
| FQ4 2024 (Nov 2024) | -1.76 | -1.76 | 0.596328B | 2.85% | 596.33M |
| FQ3 2024 (Jul 2024) | -0.91 | -0.91 | 0.525188B | 0.41% | 525.19M |
| FQ2 2024 (Apr 2024) | -2.23 | -2.23 | 0.457597B | -5.62% | 457.6M |
| FQ1 2024 (Jan 2024) | 2.47 | 2.47 | 0.73895B | -141.03% | 738.95M |
FQ4 Announce Date
02/02/2026 (Pre-Market)
Consensus EPS Estimates
3.36
Consensus Revenue Estimates
0.742B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 3.42 | -- | 3.41128 | 3.42872 | 1 |
| FQ4 2026 (Oct 2026) | 1.01 | 48.51 | 1.00742 | 1.01258 | 1 |
| FQ3 2026 (Jul 2026) | -0.61 | -193.44 | -0.61156 | -0.60844 | 1 |
| FQ2 2026 (Apr 2026) | -1.83 | -10.38 | -1.83467 | -1.82533 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Feb 2027) | 0.75B | -- | 0.75B | 0.75B | 1 |
| FQ4 2026 (Oct 2026) | 0.6B | -2.19 | 0.6B | 0.6B | 1 |
| FQ3 2026 (Jul 2026) | 0.54B | -1.29 | 0.54B | 0.54B | 1 |
| FQ2 2026 (Apr 2026) | 0.47B | -1.71 | 0.47B | 0.47B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.52 | 0.52 | 100% | |
| FQ3 2025 (Aug 2025) | -1.79 | -1.79 | 100% | |
| FQ2 2025 (May 2025) | -2.02 | -2.02 | 100% | |
| FQ1 2025 (Feb 2025) | 2.99 | 2.99 | 100% | |
| FQ4 2024 (Nov 2024) | -1.76 | -1.76 | 100% | |
| FQ3 2024 (Jul 2024) | -0.91 | -0.91 | 100% | |
| FQ2 2024 (Apr 2024) | -2.23 | -2.23 | 100% | |
| FQ1 2024 (Jan 2024) | 2.47 | 2.47 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $0.62B | $616.22M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $0.55B | $545.97M | 100% |
| FQ2 2025 (May 2025) | $0B | $0.47B | $473.97M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $0.75B | $745.95M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $0.6B | $596.33M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.53B | $525.19M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.46B | $457.6M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.74B | $738.95M | 100% |